Table 2.
Secondary endpoints change from baseline*
Variable (range: 0–100, higher is better) | Data Point | Ginseng (SD) | Placebo (SD) | P |
---|---|---|---|---|
MFSI-SF Physical | 4 weeks† | 1.6 (15.9) | −0.4 (14.7) | .39 |
8 weeks‡ | 3.0 (17.9) | −1.7 (18.2) | .004 | |
MFSI-SF Mental | 4 weeks† | 2.0 (15.2) | 0.6 (16.1) | .41 |
8 weeks‡ | 2.8 (16.5) | 3.4 (15.2) | .80 | |
MFSI-SF Emotional | 4 weeks† | 0.5 (16.1) | 0.5 (16.7) | .99 |
8 weeks‡ | 3.0 (17.4) | 2.3 (17.4) | .68 | |
MFSI-SF Vigor | 4 weeks† | 1.8 (19.0) | 0.4 (15.5) | .70 |
8 weeks‡ | 4.6 (20.5) | 2.5 (17.6) | .71 | |
MFSI-SF total score | 4 weeks† | 4.1 (13.4) | 2.1 (12.9) | .21 |
8 weeks‡ | 6.7 (14.0) | 3.7 (14.6) | .02 | |
POMS | ||||
Fatigue inertia | 4 weeks§ | 14.5 (25) | 7.7 (23.6) | .08 |
8 weeks|| | 18.6 (24.8) | 10.2 (26.1) | .008 | |
Vigor activity | 4 weeks§ | 5 (18.7) | 3.9 (17.3) | .79 |
8 weeks|| | 8.2 (19.8) | 6.4 (19.8) | .47 |
* MFSI = Multidimensional Fatigue Symptom Inventory–Short Form; POMS = Profile of Mood States; SD = standard deviation.
† n = 147 in the ginseng arm and n = 152 in the placebo arm at 4 weeks.
‡ n = 138 in the ginseng arm and n = 132 in the placebo arm at 8 weeks.
§ n = 139 in the ginseng arm and n = 142 in the placebo arm at 4 weeks.
|| n = 132 in the ginseng arm and n = 128 in the placebo arm at 8 weeks.